INR 325.25
(-0.15%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 6.26 Billion INR | 4.28% |
2022 | 6.01 Billion INR | 3.67% |
2021 | 5.79 Billion INR | 4.31% |
2020 | 5.55 Billion INR | -13.66% |
2019 | 6.43 Billion INR | -12.15% |
2018 | 7.32 Billion INR | -2.39% |
2017 | 7.5 Billion INR | -1.86% |
2016 | 7.65 Billion INR | -4.94% |
2015 | 8.04 Billion INR | -4.32% |
2014 | 8.41 Billion INR | 0.8% |
2013 | 8.34 Billion INR | 16.28% |
2012 | 7.17 Billion INR | 25.0% |
2011 | 5.74 Billion INR | 24.56% |
2010 | 4.6 Billion INR | 31.64% |
2009 | 3.5 Billion INR | 18.0% |
2008 | 2.96 Billion INR | 42.58% |
2007 | 2.08 Billion INR | 33.76% |
2006 | 1.55 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 6.6 Billion INR | 0.0% |
2024 Q1 | - INR | -100.0% |
2023 Q2 | 6.4 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 6.26 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 6.26 Billion INR | 4.28% |
2022 Q2 | 5.82 Billion INR | 0.0% |
2022 FY | 6.01 Billion INR | 3.67% |
2022 Q4 | 6.01 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 5.79 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 6.07 Billion INR | 0.0% |
2021 FY | 5.79 Billion INR | 4.31% |
2020 FY | 5.55 Billion INR | -13.66% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 5.52 Billion INR | 0.0% |
2020 Q4 | 5.55 Billion INR | 0.0% |
2019 Q4 | 6.43 Billion INR | 0.0% |
2019 FY | 6.43 Billion INR | -12.15% |
2019 Q2 | 7.06 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2018 FY | 7.32 Billion INR | -2.39% |
2018 Q4 | 7.32 Billion INR | 0.0% |
2017 FY | 7.5 Billion INR | -1.86% |
2016 FY | 7.65 Billion INR | -4.94% |
2016 Q4 | 8.29 Billion INR | 0.0% |
2015 FY | 8.04 Billion INR | -4.32% |
2014 FY | 8.41 Billion INR | 0.8% |
2013 Q4 | 8.34 Billion INR | 0.0% |
2013 FY | 8.34 Billion INR | 16.28% |
2012 Q4 | 7.17 Billion INR | 0.0% |
2012 Q2 | 1.29 Billion INR | 0.0% |
2012 FY | 7.17 Billion INR | 25.0% |
2011 FY | 5.74 Billion INR | 24.56% |
2010 FY | 4.6 Billion INR | 31.64% |
2009 FY | 3.5 Billion INR | 18.0% |
2008 FY | 2.96 Billion INR | 42.58% |
2007 FY | 2.08 Billion INR | 33.76% |
2006 FY | 1.55 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Ajanta Pharma Limited | 46.38 Billion INR | 86.486% |
Amrutanjan Health Care Limited | 3.66 Billion INR | -70.859% |
Sigachi Industries Limited | 6.94 Billion INR | 9.699% |
Bal Pharma Limited | 3.2 Billion INR | -95.647% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 46.2% |
Medico Remedies Limited | 961.95 Million INR | -551.622% |
Lasa Supergenerics Limited | 1.5 Billion INR | -315.48% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -21.705% |
Alpa Laboratories Limited | 1.82 Billion INR | -243.24% |
Nectar Lifesciences Limited | 21.91 Billion INR | 71.391% |
Shilpa Medicare Limited | 30.93 Billion INR | 79.735% |
Aarti Drugs Limited | 24.32 Billion INR | 74.23% |
Lupin Limited | 239.97 Billion INR | 97.388% |
Aurobindo Pharma Limited | 450.71 Billion INR | 98.609% |
Zydus Lifesciences Limited | 292.8 Billion INR | 97.859% |
Windlas Biotech Limited | 6.26 Billion INR | -0.1% |
Suven Life Sciences Limited | 2.84 Billion INR | -120.015% |
Eris Lifesciences Limited | 70.48 Billion INR | 91.107% |
Valiant Laboratories Limited | 3.42 Billion INR | -82.916% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 84.306% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 73.337% |
Ipca Laboratories Limited | 111.01 Billion INR | 94.354% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 48.361% |
Achyut Healthcare Limited | 309.52 Million INR | -1925.155% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.267% |
Bajaj HealthCare Limited | 7.65 Billion INR | 18.075% |
RPG Life Sciences Limited | 5.12 Billion INR | -22.22% |
Mankind Pharma Limited | 119.63 Billion INR | 94.76% |
Laurus Labs Limited | 83.87 Billion INR | 92.526% |
Piramal Pharma Limited | 153.11 Billion INR | 95.906% |
Syncom Formulations (India) Limited | 4.04 Billion INR | -54.901% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 95.838% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 90.275% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 95.634% |
Unichem Laboratories Limited | 31.69 Billion INR | 80.222% |
Sequent Scientific Limited | 15.4 Billion INR | 59.307% |
Novartis India Limited | 9.24 Billion INR | 32.229% |
Wanbury Limited | 3.43 Billion INR | -82.487% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 72.191% |
Wockhardt Limited | 76.49 Billion INR | 91.805% |
Themis Medicare Limited | 5.66 Billion INR | -10.666% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -188.758% |
Jubilant Pharmova Limited | 115.48 Billion INR | 94.572% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 78.009% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.382% |
Divi's Laboratories Limited | 154.7 Billion INR | 95.948% |
NATCO Pharma Limited | 69.06 Billion INR | 90.924% |
Gufic Biosciences Limited | 10.92 Billion INR | 42.626% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 72.071% |
Ind-Swift Limited | 6.54 Billion INR | 4.223% |
Procter & Gamble Health Limited | 7.94 Billion INR | 21.09% |
FDC Limited | 24.68 Billion INR | 74.603% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -251.806% |
Granules India Limited | 55.2 Billion INR | 88.646% |
Medicamen Biotech Limited | 2.94 Billion INR | -112.829% |
Alkem Laboratories Limited | 155.74 Billion INR | 95.975% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 41.854% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -1231.338% |
Brooks Laboratories Limited | 904.45 Million INR | -593.048% |
Megasoft Limited | 3.65 Billion INR | -71.312% |
ZIM Laboratories Limited | 4.46 Billion INR | -40.286% |
Strides Pharma Science Limited | 58.39 Billion INR | 89.266% |
Neuland Laboratories Limited | 18.32 Billion INR | 65.795% |
Morepen Laboratories Limited | 12.93 Billion INR | 51.529% |
Hikal Limited | 24.87 Billion INR | 74.797% |
Indoco Remedies Limited | 21.44 Billion INR | 70.773% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 75.724% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -161.112% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -87.998% |
Hester Biosciences Limited | 6.62 Billion INR | 5.362% |